A clinical analysis of bone mineral density after chemotherapy in 23 young patients with gynecological malignancies.

Xu Qiying,Sun Xiuli,Li Xiaoping
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2011.06.008
2011-01-01
Abstract:Objective:To invesitgate the charactristics of change of the bone mineral density(BMD) after chemotherapy in young gynecological malignancies for providing a basis for the clinical prevention of osteoporosis after chemotherapy.Methods:23 young patients(≤40 years old) with gynecological malignancies who accepted chemotherapy were divided into 2 groups according to age(≤26 years old and >26 years old).The BMD was detected on the lumbar spine,proximal femur and forearm respectively,and their serum hormone levels and blood magnesium,calcium and phosphate ions levels were determined at the same time.Results:(1)For all 23 patients,the incidence of BMD reduction was 43.5%.In the group≤26 years old,BMD decreased in 6 cases(66.7%,6/9) and 4 cases in the group >26 years old(28.57%,4/14).Lumbar spine L1~L4 BMD in the group≤26 years old was significantly lower than that of the group>26 years old(P<0.05).(2)The difference of the incidence of BMD reduction was not significant between the patients accepted chemotherapy alone and combined with radiotherapy.(3)The LH and FSH levels were significantly different between the two groups(P<0.05),while the other hormones and electrolyte levels were not significantly different.Conclusion:The young patients with gynecological malignancies prone to have a decrease in BMD during chemotherapy,even have the possibility of osteoporosis.The research in prevention and treatment to improve the quality of life for the patients is very important.
What problem does this paper attempt to address?